Identification of <em>Candida</em> species isolated from cancer patients by Polymerase Chain Reaction &ndash; Restriction Fragment Length Polymorphism in Apeksha Hospital, Maharagama, Sri Lanka
Candida infections pose a significant challenge in managing cancer patients. A rapid and effective method for Candida species identification is crucial to address this issue. This study at Apeksha Hospital, Maharagama, aimed to identify Candida species using Polymerase Chain Reaction – Restriction Fragment Length Polymorphism. ITS1-5.8S-ITS2 rDNA regions of 52 clinical Candida isolates and standard strains were amplified using ITS1 and ITS4 primers and digested with MspI enzyme. Candida tropicalis (38%), Candida parapsilosis (31%), Candida albicans (13%), Candida glabrata (8%), Candida krusei (4%), Candida haemulonii (4%), and Candida intermedia (2%) were identified. PCRRFLP proves to be a rapid, and reliable method for identifying medically important Candida species in cancer patients.
Authors
- S.W.S.B. Dasanayaka (ORCID: https://orcid.org/0000-0002-1584-0673)
- Gaya Kaushalya
- S. P. Gunasekera
- Somalatha Wijendra
- Ramesh Ratnasingham
- S. Ganguli
Institutions
- University of Sri Jayewardenepura (LK)
- Medical Research Institute (LK)
Publication Details
- Journal
- Ceylon Medical Journal
- Published
- 2024-08-16
- DOI
- https://doi.org/10.4038/cmj.v68i3.9928
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00